id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT01758042 | 27:35:treatment,, | Participants should be on dialysis or have an estimated or measured CrCl < 35 ml/min | 2 | [
"Participants",
"should",
"be",
"on",
"dialysis",
"or",
"have",
"an",
"estimated",
"or",
"measured",
"CrCl",
"<",
"35",
"ml/min"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01822522 | 62:71:treatment,76:79:treatment,76:89:chronic_disease,101:127:treatment | Participating participants MUST receive appropriate care and treatment for HIV infection, including antiretroviral medications, when clinically indicated and should be under the care of a physician experienced in HIV management | 2 | [
"Participating",
"participants",
"MUST",
"receive",
"appropriate",
"care",
"and",
"treatment",
"for",
"HIV",
"infection",
",",
"including",
"antiretroviral",
"medications",
",",
"when",
"clinically",
"indicated",
"and",
"should",
"be",
"under",
"the",
"care",
"of",
... | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
2,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02557321 | ,99:120:treatment | who have failed to achieve a complete or partial response within 24 weeks following initiation of checkpoint inhibition | 2 | [
"who",
"have",
"failed",
"to",
"achieve",
"a",
"complete",
"or",
"partial",
"response",
"within",
"24",
"weeks",
"following",
"initiation",
"of",
"checkpoint",
"inhibition"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02577406 | 67:75:cancer,97:105:chronic_disease,107:116:chronic_disease,122:129:chronic_disease,133:138:chronic_disease,147:185:chronic_disease | Subject has immediately life-threatening, severe complications of leukemia such as uncontrolled bleeding, pneumonia with hypoxia or shock, and/or disseminated intravascular coagulation | 2 | [
"Subject",
"has",
"immediately",
"life-threatening",
",",
"severe",
"complications",
"of",
"leukemia",
"such",
"as",
"uncontrolled",
"bleeding",
",",
"pneumonia",
"with",
"hypoxia",
"or",
"shock",
",",
"and/or",
"disseminated",
"intravascular",
"coagulation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
2,
0,
2,
0,
2,
0,
2,
0,
0,
2,
2,
2
] |
NCT02150967 | 1:20:treatment | BGJ398/infigratinib (all cohorts) | 2 | [
"BGJ398/infigratinib",
"(",
"all",
"cohorts",
")"
] | [
1,
0,
0,
0,
0
] |
NCT02257424 | 165:185:treatment,,,,,,,278:299:treatment,306:314:treatment,339:356:treatment,379:394:treatment,403:439:treatment,441:448:treatment,454:464:treatment | Current use of a prohibited medication as described in Section 6.3.8 of the protocol for Potential for Drug-Drug Interaction: apply moisturizing creams frequently, topical keratolytics (e.g. urea 20-40 % cream, salicylic acid 6%, tazarotene 0.1% cream, fluorouracil 5% cream), clobetasol propionate 0.05% ointment for er... | 2 | [
"Current",
"use",
"of",
"a",
"prohibited",
"medication",
"as",
"described",
"in",
"Section",
"6.3.8",
"of",
"the",
"protocol",
"for",
"Potential",
"for",
"Drug-Drug",
"Interaction",
":",
"apply",
"moisturizing",
"creams",
"frequently",
",",
"topical",
"keratolytic... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02885649 | 37:62:chronic_disease, | History of loss of consciousness or transient ischemic attack within twelve (12) months of enrollment | 2 | [
"History",
"of",
"loss",
"of",
"consciousness",
"or",
"transient",
"ischemic",
"attack",
"within",
"twelve",
"(",
"12",
")",
"months",
"of",
"enrollment"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02409810 | 1:20:chronic_disease | Acute liver failure | 2 | [
"Acute",
"liver",
"failure"
] | [
2,
2,
2
] |
NCT02312245 | 23:29:cancer | Prior consent to have tumors used for unspecified future research | 2 | [
"Prior",
"consent",
"to",
"have",
"tumors",
"used",
"for",
"unspecified",
"future",
"research"
] | [
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02774421 | 1:16:chronic_disease | cardiac disease risk factors | 2 | [
"cardiac",
"disease",
"risk",
"factors"
] | [
2,
2,
0,
0
] |
NCT02268253 | 1:25:cancer | non-melanoma skin cancer | 2 | [
"non-melanoma",
"skin",
"cancer"
] | [
3,
3,
3
] |
NCT02414139 | ,72:84:treatment | Patients with characterized EGFR mutations that predict sensitivity to EGFR therapy, including, but not limited to exon 19 deletions and exon 21 mutations | 2 | [
"Patients",
"with",
"characterized",
"EGFR",
"mutations",
"that",
"predict",
"sensitivity",
"to",
"EGFR",
"therapy",
",",
"including",
",",
"but",
"not",
"limited",
"to",
"exon",
"19",
"deletions",
"and",
"exon",
"21",
"mutations"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02562716 | 59:84:cancer | Patients must have histologically or cytologically proven pancreatic adenocarcinoma | 2 | [
"Patients",
"must",
"have",
"histologically",
"or",
"cytologically",
"proven",
"pancreatic",
"adenocarcinoma"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT02394704 | 5:32:treatment,34:43:treatment,45:75:treatment,86:131:treatment | Any implanted electrical device (pacemaker, vagus nerve stimulator implant, etc.) or prior treatment with a vagus nerve stimulator | 2 | [
"Any",
"implanted",
"electrical",
"device",
"(",
"pacemaker",
",",
"vagus",
"nerve",
"stimulator",
"implant",
",",
"etc",
".",
")",
"or",
"prior",
"treatment",
"with",
"a",
"vagus",
"nerve",
"stimulator"
] | [
0,
1,
1,
1,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1
] |
NCT01365169 | 21:28:chronic_disease,32:49:chronic_disease,65:80:chronic_disease,82:135:chronic_disease,138:141:chronic_disease | Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (New York Heart Association functional class III or IV) (PCS study) | 2 | [
"Underlying",
"unstable",
"cardiac",
"or",
"pulmonary",
"disease",
"or",
"symptomatic",
"cardiac",
"disease",
"(",
"New",
"York",
"Heart",
"Association",
"functional",
"class",
"III",
"or",
"IV",
")",
"(",
"PCS",
"study",
")"
] | [
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
2,
2,
2,
2,
0,
0,
2,
0,
0
] |
NCT01980823 | 56:70:treatment,72:75:chronic_disease,76:95:treatment,101:113:treatment,150:162:treatment | Strong Cytochrome P450 3A4 (abbreviated CYP3A4) (e.g., clarithromycin, HIV protease inhibitors, and itraconazole), given potential interactions with atorvastatin | 2 | [
"Strong",
"Cytochrome",
"P450",
"3A4",
"(",
"abbreviated",
"CYP3A4",
")",
"(",
"e.g.",
",",
"clarithromycin",
",",
"HIV",
"protease",
"inhibitors",
",",
"and",
"itraconazole",
")",
",",
"given",
"potential",
"interactions",
"with",
"atorvastatin"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
2,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1
] |
NCT02404155 | 21:39:chronic_disease | DSM-IV diagnosis of Mental Retardation | 2 | [
"DSM-IV",
"diagnosis",
"of",
"Mental",
"Retardation"
] | [
0,
0,
0,
2,
2
] |
NCT02734888 | 1:18:chronic_disease | Diabetes mellitus | 2 | [
"Diabetes",
"mellitus"
] | [
2,
2
] |
NCT03130907 | 15:30:chronic_disease | Patients with solitary kidney | 2 | [
"Patients",
"with",
"solitary",
"kidney"
] | [
0,
0,
2,
2
] |
NCT02925923 | 1:11:treatment | Dabigatran | 2 | [
"Dabigatran"
] | [
1
] |
NCT02573493 | ,,16:30:cancer | Arm 3: T2T1-T4 primary tumors | 2 | [
"Arm",
"3",
":",
"T2T1-T4",
"primary",
"tumors"
] | [
0,
0,
0,
0,
3,
3
] |
NCT02826681 | ,61:64:chronic_disease,71:78:treatment,80:117:treatment,119:135:treatment,137:172:treatment,177:208:treatment | Current (past 4 weeks) use of drugs that may cause or treat RLS, e.g. opioids, calcium channel alpha-2-delta ligands, anti-depressants, dopaminergic agonist or antagonists, or centrally-acting antihistamines | 2 | [
"Current",
"(",
"past",
"4",
"weeks",
")",
"use",
"of",
"drugs",
"that",
"may",
"cause",
"or",
"treat",
"RLS",
",",
"e.g",
".",
"opioids",
",",
"calcium",
"channel",
"alpha-2-delta",
"ligands",
",",
"anti-depressants",
",",
"dopaminergic",
"agonist",
"or",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
1,
0,
1,
1,
1,
1,
0,
1,
0,
1,
1,
1,
1,
0,
0,
1,
1
] |
NCT03021538 | 37:41:treatment | Patients bridged to transplant with ECMO | 2 | [
"Patients",
"bridged",
"to",
"transplant",
"with",
"ECMO"
] | [
0,
0,
0,
0,
0,
1
] |
NCT02216227 | 9:28:treatment,32:50:treatment,71:83:treatment,87:98:treatment | Undergo cardiac transplants or cardiac procedures performed using the percutaneous or thoracotomy approach | 2 | [
"Undergo",
"cardiac",
"transplants",
"or",
"cardiac",
"procedures",
"performed",
"using",
"the",
"percutaneous",
"or",
"thoracotomy",
"approach"
] | [
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT01943851 | 1:4:treatment | ECG findings or assessments | 2 | [
"ECG",
"findings",
"or",
"assessments"
] | [
1,
0,
0,
0
] |
NCT02726906 | 1:11:chronic_disease | Depression | 2 | [
"Depression"
] | [
2
] |
NCT02413047 | 28:39:treatment | Previous noncompliant with medications | 2 | [
"Previous",
"noncompliant",
"with",
"medications"
] | [
0,
0,
0,
1
] |
NCT02540330 | 13:29:chronic_disease | Presence of pleural effusion | 2 | [
"Presence",
"of",
"pleural",
"effusion"
] | [
0,
0,
2,
2
] |
NCT02043548 | 20:37:cancer,39:51:cancer,,101:127:cancer,132:144:cancer,153:158:cancer,163:186:cancer,202:233:cancer, | Evidence of active malignant disease, malignancies diagnosed within the previous 5 years (including hematological malignancies and solid tumors, except basal and squamous cell carcinoma of the skin or carcinoma in situ of the cervix uteri that has been excised and cured), or breast cancer diagnosed within the previous ... | 2 | [
"Evidence",
"of",
"active",
"malignant",
"disease",
",",
"malignancies",
"diagnosed",
"within",
"the",
"previous",
"5",
"years",
"(",
"including",
"hematological",
"malignancies",
"and",
"solid",
"tumors",
",",
"except",
"basal",
"and",
"squamous",
"cell",
"carcin... | [
0,
0,
0,
3,
3,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
0,
0,
3,
0,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02573493 | 18:37:cancer, | History of prior invasive malignancy diagnosed within 3 years prior to study enrollment | 2 | [
"History",
"of",
"prior",
"invasive",
"malignancy",
"diagnosed",
"within",
"3",
"years",
"prior",
"to",
"study",
"enrollment"
] | [
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02078102 | 33:65:treatment | Patients must not have received prior bone seeking radionuclides | 2 | [
"Patients",
"must",
"not",
"have",
"received",
"prior",
"bone",
"seeking",
"radionuclides"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT01968590 | 1:26:treatment,, | vitamin D supplementation in the last 3 months equal to or greater than 600IU per day | 2 | [
"vitamin",
"D",
"supplementation",
"in",
"the",
"last",
"3",
"months",
"equal",
"to",
"or",
"greater",
"than",
"600IU",
"per",
"day"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01853163 | 26:56:treatment | Patient scheduled for an orthopaedic surgical procedure | 2 | [
"Patient",
"scheduled",
"for",
"an",
"orthopaedic",
"surgical",
"procedure"
] | [
0,
0,
0,
0,
1,
1,
1
] |
NCT02124902 | 28:38:allergy_name | Prior allergic reaction to gadolinium-based MR contrast agents | 2 | [
"Prior",
"allergic",
"reaction",
"to",
"gadolinium-based",
"MR",
"contrast",
"agents"
] | [
0,
0,
0,
0,
4,
0,
0,
0
] |
NCT02786251 | 9:15:cancer, | Current cancer or cancer that has been in remission for < 5 years | 2 | [
"Current",
"cancer",
"or",
"cancer",
"that",
"has",
"been",
"in",
"remission",
"for",
"<",
"5",
"years"
] | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01829958 | ,,45:65:chronic_disease | Patients scoring ≥ 11 on the BOMC (implying cognitive impairment) will be excluded since their ability to reliably complete the questionnaire will be in doubt Subjects meeting the following criteria will be excluded from enrollment in the pre-phase arm of the study, but may be included in the GA only arm | 2 | [
"Patients",
"scoring",
"≥",
"11",
"on",
"the",
"BOMC",
"(",
"implying",
"cognitive",
"impairment",
")",
"will",
"be",
"excluded",
"since",
"their",
"ability",
"to",
"reliably",
"complete",
"the",
"questionnaire",
"will",
"be",
"in",
"doubt",
"Subjects",
"meeti... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02057133 | 14:25:treatment,28:39:treatment,42:52:treatment,,101:121:treatment,126:144:cancer | For Part H: (abemaciclib + trastuzumab + pertuzumab): The participant must have received at least 1 chemotherapy regimen for metastatic disease | 2 | [
"For",
"Part",
"H",
":",
"(",
"abemaciclib",
"+",
"trastuzumab",
"+",
"pertuzumab",
")",
":",
"The",
"participant",
"must",
"have",
"received",
"at",
"least",
"1",
"chemotherapy",
"regimen",
"for",
"metastatic",
"disease"
] | [
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
3,
3
] |
NCT03055377 | ,60:81:chronic_disease | Must meet current (within last 30 days) DSM-5 criteria for cannabis use disorder | 2 | [
"Must",
"meet",
"current",
"(",
"within",
"last",
"30",
"days",
")",
"DSM-5",
"criteria",
"for",
"cannabis",
"use",
"disorder"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT03023449 | 12:37:chronic_disease,46:52:chronic_disease,56:93:chronic_disease | History of chronic pulmonary disease such as asthma or chronic obstructive pulmonary disease | 2 | [
"History",
"of",
"chronic",
"pulmonary",
"disease",
"such",
"as",
"asthma",
"or",
"chronic",
"obstructive",
"pulmonary",
"disease"
] | [
0,
0,
2,
2,
2,
2,
0,
2,
0,
0,
0,
0,
0
] |
NCT02755896 | 1:28:cancer | Stage 1 (pT1) breast cancer, excised with negative margins | 2 | [
"Stage",
"1",
"(",
"pT1",
")",
"breast",
"cancer",
",",
"excised",
"with",
"negative",
"margins"
] | [
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT03188185 | 14:49:treatment,,96:99:treatment,122:149:treatment | Has received electroconvulsive therapy treatment within the last 2 years or within the current MDE or failed a course of electroconvulsive treatment at any time | 2 | [
"Has",
"received",
"electroconvulsive",
"therapy",
"treatment",
"within",
"the",
"last",
"2",
"years",
"or",
"within",
"the",
"current",
"MDE",
"or",
"failed",
"a",
"course",
"of",
"electroconvulsive",
"treatment",
"at",
"any",
"time"
] | [
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03078023 | ,,40:68:treatment | Esophageal minimal diameter < 13 mm on structured barium esophagram | 2 | [
"Esophageal",
"minimal",
"diameter",
"<",
"13",
"mm",
"on",
"structured",
"barium",
"esophagram"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01061515 | 1:26:chronic_disease,83:100:chronic_disease,102:120:chronic_disease | Gastrointestinal ailments that may alter the absorption of oral medications (i.e. bowel obstruction, short-gut syndrome) | 2 | [
"Gastrointestinal",
"ailments",
"that",
"may",
"alter",
"the",
"absorption",
"of",
"oral",
"medications",
"(",
"i.e",
".",
"bowel",
"obstruction",
",",
"short-gut",
"syndrome",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0
] |
NCT02721303 | 12:29:treatment | Use of any weight loss drugs | 2 | [
"Use",
"of",
"any",
"weight",
"loss",
"drugs"
] | [
0,
0,
0,
1,
1,
1
] |
NCT02945800 | 1:30:treatment,23:30:treatment,55:84:treatment, | Myelosuppressive chemotherapy: Must not have received myelosuppressive chemotherapy within 3 weeks of protocol therapy on this study | 2 | [
"Myelosuppressive",
"chemotherapy",
":",
"Must",
"not",
"have",
"received",
"myelosuppressive",
"chemotherapy",
"within",
"3",
"weeks",
"of",
"protocol",
"therapy",
"on",
"this",
"study"
] | [
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01754779 | 1:15:chronic_disease | Hypercalciuric CaP stone formers | 2 | [
"Hypercalciuric",
"CaP",
"stone",
"formers"
] | [
2,
0,
0,
0
] |
NCT02606045 | 1:10:treatment,16:21:treatment,23:38:treatment,40:51:treatment,53:59:treatment,64:97:treatment, | Treatment with DDAVP, cryoprecipitate, whole blood, plasma and plasma derivatives containing VWF within 5 days of study | 2 | [
"Treatment",
"with",
"DDAVP",
",",
"cryoprecipitate",
",",
"whole",
"blood",
",",
"plasma",
"and",
"plasma",
"derivatives",
"containing",
"VWF",
"within",
"5",
"days",
"of",
"study"
] | [
1,
0,
1,
0,
1,
0,
1,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01500551 | 1:11:chronic_disease | Infections | 2 | [
"Infections"
] | [
2
] |
NCT02335671 | 36:64:cancer | Participants with prior history of ipsilateral breast carcinoma | 2 | [
"Participants",
"with",
"prior",
"history",
"of",
"ipsilateral",
"breast",
"carcinoma"
] | [
0,
0,
0,
0,
0,
3,
3,
3
] |
NCT02522468 | 1:25:cancer | Locally advanced disease | 2 | [
"Locally",
"advanced",
"disease"
] | [
3,
3,
3
] |
NCT02207439 | 31:44:chronic_disease | Subjects with moderate-severe renal disease | 2 | [
"Subjects",
"with",
"moderate-severe",
"renal",
"disease"
] | [
0,
0,
0,
2,
2
] |
NCT03110354 | 24:31:chronic_disease,33:46:chronic_disease,51:68:chronic_disease | Has substance abuse or medical, psychological, or social conditions that, in the opinion of the Investigator, may interfere with the subject's participation in the clinical study or evaluation of the clinical study results | 2 | [
"Has",
"substance",
"abuse",
"or",
"medical",
",",
"psychological",
",",
"or",
"social",
"conditions",
"that",
",",
"in",
"the",
"opinion",
"of",
"the",
"Investigator",
",",
"may",
"interfere",
"with",
"the",
"subject",
"'s",
"participation",
"in",
"the",
"c... | [
0,
0,
0,
0,
2,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01947140 | 10:32:treatment | No other investigational agents are allowed | 2 | [
"No",
"other",
"investigational",
"agents",
"are",
"allowed"
] | [
0,
0,
1,
1,
0,
0
] |
NCT02025465 | ,,58:71:chronic_disease | Known ejection fraction <45%, regardless of a history of heart failure | 2 | [
"Known",
"ejection",
"fraction",
"<",
"45",
"%",
",",
"regardless",
"of",
"a",
"history",
"of",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02250157 | 27:37:allergy_name,41:62:allergy_name,78:106:allergy_name | Allergy or sensitivity to irinotecan or cranberry-grape juice, or any of the irinotecan tablet excipients | 2 | [
"Allergy",
"or",
"sensitivity",
"to",
"irinotecan",
"or",
"cranberry-grape",
"juice",
",",
"or",
"any",
"of",
"the",
"irinotecan",
"tablet",
"excipients"
] | [
0,
0,
0,
0,
4,
4,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02480114 | 12:19:chronic_disease | History of seizure disorder | 2 | [
"History",
"of",
"seizure",
"disorder"
] | [
0,
0,
2,
0
] |
NCT03168776 | 22:64:treatment | contraindications to anti-platelet and/or anticoagulant therapy | 2 | [
"contraindications",
"to",
"anti-platelet",
"and/or",
"anticoagulant",
"therapy"
] | [
0,
0,
1,
1,
1,
1
] |
NCT02553161 | 23:37:treatment | a history of previous antidepressant exposure | 2 | [
"a",
"history",
"of",
"previous",
"antidepressant",
"exposure"
] | [
0,
0,
0,
0,
1,
0
] |
NCT02008136 | 8:14:chronic_disease | recent stroke | 2 | [
"recent",
"stroke"
] | [
0,
2
] |
NCT02346526 | 1:19:chronic_disease | Fecal incontinence | 2 | [
"Fecal",
"incontinence"
] | [
2,
2
] |
NCT02359825 | 43:63:treatment | unlikely to complete the normal regime of occupational therapy | 2 | [
"unlikely",
"to",
"complete",
"the",
"normal",
"regime",
"of",
"occupational",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02347995 | 29:49:chronic_disease | hemodynamically significant valvular dysfunction | 2 | [
"hemodynamically",
"significant",
"valvular",
"dysfunction"
] | [
0,
0,
2,
2
] |
NCT02390752 | ,59:100:treatment,107:117:treatment,,174:187:treatment | Others: greater than or equal to 7 days from last dose of short active hematopoietic growth factors, i.e. filgrastim, greater than or equal to 14 days for long-acting, i.e. pegfilgrastim | 2 | [
"Others",
":",
"greater",
"than",
"or",
"equal",
"to",
"7",
"days",
"from",
"last",
"dose",
"of",
"short",
"active",
"hematopoietic",
"growth",
"factors",
",",
"i.e",
".",
"filgrastim",
",",
"greater",
"than",
"or",
"equal",
"to",
"14",
"days",
"for",
"l... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02484937 | 49:62:chronic_disease,64:80:chronic_disease,85:102:chronic_disease | Significant psychiatric history: a diagnosis of schizophrenia, bipolar disorder, or severe depression | 2 | [
"Significant",
"psychiatric",
"history",
":",
"a",
"diagnosis",
"of",
"schizophrenia",
",",
"bipolar",
"disorder",
",",
"or",
"severe",
"depression"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
2,
2
] |
NCT03114020 | ,,84:103:treatment,105:123:treatment,125:148:treatment,153:156:treatment, | men who are sexually active must agree to use an adequate method of contraception (oral contraceptives, depot progesterone, condom plus spermicidal, or IUD) during the study and for 1 month after the final dose of study drug | 2 | [
"men",
"who",
"are",
"sexually",
"active",
"must",
"agree",
"to",
"use",
"an",
"adequate",
"method",
"of",
"contraception",
"(",
"oral",
"contraceptives",
",",
"depot",
"progesterone",
",",
"condom",
"plus",
"spermicidal",
",",
"or",
"IUD",
")",
"during",
"t... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
1,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02145260 | 8:16:treatment | Use of pressors | 2 | [
"Use",
"of",
"pressors"
] | [
0,
0,
1
] |
NCT02167958 | 25:42:treatment,83:113:cancer,145:151:cancer,158:166:cancer | Greater than 1 cycle of induction therapy required to achieve remission Preceding myelodysplastic syndrome (MDS) Presence of Flt3 abnormalities FAB M6 or M7 leukemia | 2 | [
"Greater",
"than",
"1",
"cycle",
"of",
"induction",
"therapy",
"required",
"to",
"achieve",
"remission",
"Preceding",
"myelodysplastic",
"syndrome",
"(",
"MDS",
")",
"Presence",
"of",
"Flt3",
"abnormalities",
"FAB",
"M6",
"or",
"M7",
"leukemia"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
3
] |
NCT03130777 | 1:7:chronic_disease,, | anemia (Hgb < 7 g/dL) | 2 | [
"anemia",
"(",
"Hgb",
"<",
"7",
"g/dL",
")"
] | [
2,
0,
0,
0,
0,
0,
0
] |
NCT01695967 | 1:23:chronic_disease | craniofacial anomalies | 2 | [
"craniofacial",
"anomalies"
] | [
2,
2
] |
NCT02035085 | 1:15:chronic_disease | Claustrophobic | 2 | [
"Claustrophobic"
] | [
2
] |
NCT02286843 | 15:33:chronic_disease | biopsy proven metastatic disease | 2 | [
"biopsy",
"proven",
"metastatic",
"disease"
] | [
0,
0,
2,
2
] |
NCT01494662 | 68:89:treatment | These patients may include those who have received or not received previous treatment(s) for their CNS | 2 | [
"These",
"patients",
"may",
"include",
"those",
"who",
"have",
"received",
"or",
"not",
"received",
"previous",
"treatment",
"(",
"s",
")",
"for",
"their",
"CNS"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02992275 | 22:41:allergy_name,80:92:chronic_disease,96:112:chronic_disease,133:141:chronic_disease,154:179:chronic_disease | Contraindications to resistance training, including a self-reported history of intracranial or retinal bleeding in the last year or Diabetes with active proliferative retinopathy | 2 | [
"Contraindications",
"to",
"resistance",
"training",
",",
"including",
"a",
"self-reported",
"history",
"of",
"intracranial",
"or",
"retinal",
"bleeding",
"in",
"the",
"last",
"year",
"or",
"Diabetes",
"with",
"active",
"proliferative",
"retinopathy"
] | [
0,
0,
4,
4,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
2,
2
] |
NCT02992275 | 1:9:chronic_disease,, | Dementia (on medical record review or mini-mental status exam score <24) | 2 | [
"Dementia",
"(",
"on",
"medical",
"record",
"review",
"or",
"mini-mental",
"status",
"exam",
"score",
"<",
"24",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02624258 | ,29:41:treatment,, | Are more than 6 months from transplant 6) Karnofsky performance status ≥ 50 at screening | 2 | [
"Are",
"more",
"than",
"6",
"months",
"from",
"transplant",
"6",
")",
"Karnofsky",
"performance",
"status",
"≥",
"50",
"at",
"screening"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02519348 | 1:23:chronic_disease,9:23:chronic_disease,,65:76:treatment | Hepatic encephalopathy within past 12 months or requirement for medications to prevent or control encephalopathy | 2 | [
"Hepatic",
"encephalopathy",
"within",
"past",
"12",
"months",
"or",
"requirement",
"for",
"medications",
"to",
"prevent",
"or",
"control",
"encephalopathy"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02856412 | 23:27:chronic_disease,, | have some symptoms of PTSD with a current CAPS score of 23 or higher | 2 | [
"have",
"some",
"symptoms",
"of",
"PTSD",
"with",
"a",
"current",
"CAPS",
"score",
"of",
"23",
"or",
"higher"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02498262 | 79:94:chronic_disease | Participants will include individuals that have suffered a moderate to severe traumatic brain | 2 | [
"Participants",
"will",
"include",
"individuals",
"that",
"have",
"suffered",
"a",
"moderate",
"to",
"severe",
"traumatic",
"brain"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02025465 | 18:31:chronic_disease,, | Known history of heart failure with an ejection fraction <50% | 2 | [
"Known",
"history",
"of",
"heart",
"failure",
"with",
"an",
"ejection",
"fraction",
"<",
"50",
"%"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02578641 | 1:27:chronic_disease | Severe concomitant illness | 2 | [
"Severe",
"concomitant",
"illness"
] | [
2,
2,
2
] |
NCT03028350 | 50:56:chronic_disease, | no hospitalizations or emergency room visits for asthma at least three months prior to starting treatment | 2 | [
"no",
"hospitalizations",
"or",
"emergency",
"room",
"visits",
"for",
"asthma",
"at",
"least",
"three",
"months",
"prior",
"to",
"starting",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02130687 | 1:18:chronic_disease | Mental conditions rendering the subject unable to understand the nature, scope, or possible consequences of the study | 2 | [
"Mental",
"conditions",
"rendering",
"the",
"subject",
"unable",
"to",
"understand",
"the",
"nature",
",",
"scope",
",",
"or",
"possible",
"consequences",
"of",
"the",
"study"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02091141 | 31:47:treatment,,,102:117:treatment,108:117:treatment | For patients enrolling in the atezolizumab arm, ECOG score must be documented within 7 days prior to first treatment and confirmation of ECOG PS must be entered into the interactive web response system [IWRS] prior to initiation of treatment | 2 | [
"For",
"patients",
"enrolling",
"in",
"the",
"atezolizumab",
"arm",
",",
"ECOG",
"score",
"must",
"be",
"documented",
"within",
"7",
"days",
"prior",
"to",
"first",
"treatment",
"and",
"confirmation",
"of",
"ECOG",
"PS",
"must",
"be",
"entered",
"into",
"the... | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02543983 | 13:25:treatment | Agree to be hospitalized | 2 | [
"Agree",
"to",
"be",
"hospitalized"
] | [
0,
0,
0,
1
] |
NCT02469389 | 1:10:chronic_disease | anhedonia | 2 | [
"anhedonia"
] | [
2
] |
NCT03084640 | 34:57:treatment | who have previously received any anti-PD-1/PD-L1 therapy, alone or in combination | 2 | [
"who",
"have",
"previously",
"received",
"any",
"anti-PD-1/PD-L1",
"therapy",
",",
"alone",
"or",
"in",
"combination"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT01716806 | ,56:78:treatment | Measurable disease of at least 1.5 cm as documented by radiographic technique | 2 | [
"Measurable",
"disease",
"of",
"at",
"least",
"1.5",
"cm",
"as",
"documented",
"by",
"radiographic",
"technique"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02926378 | ,,,,165:171:chronic_disease | Participants must have experienced a left Cerebrovascular Accident (CVA) at least one year prior to study participation and the injury timeframe is 1-10 years post stroke | 2 | [
"Participants",
"must",
"have",
"experienced",
"a",
"left",
"Cerebrovascular",
"Accident",
"(",
"CVA",
")",
"at",
"least",
"one",
"year",
"prior",
"to",
"study",
"participation",
"and",
"the",
"injury",
"timeframe",
"is",
"1-10",
"years",
"post",
"stroke"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02641093 | 1:10:chronic_disease | infection | 2 | [
"infection"
] | [
2
] |
NCT02213068 | 17:31:chronic_disease | Recipients with EBV serostatus negative or unknown | 2 | [
"Recipients",
"with",
"EBV",
"serostatus",
"negative",
"or",
"unknown"
] | [
0,
0,
2,
2,
0,
0,
0
] |
NCT02433626 | 51:66:chronic_disease | History of clinically significant or uncontrolled cardiac disease | 2 | [
"History",
"of",
"clinically",
"significant",
"or",
"uncontrolled",
"cardiac",
"disease"
] | [
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02991651 | 1:34:cancer | non-melanoma cutaneous malignancy | 2 | [
"non-melanoma",
"cutaneous",
"malignancy"
] | [
3,
3,
3
] |
NCT03037385 | 58:107:cancer,73:78:cancer,132:135:treatment | have a pathologically documented, definitively diagnosed advanced solid tumor with an oncogenic RET fusion previously treated with SOC appropriate for the tumor type and not eligible for any of the other groups | 2 | [
"have",
"a",
"pathologically",
"documented",
",",
"definitively",
"diagnosed",
"advanced",
"solid",
"tumor",
"with",
"an",
"oncogenic",
"RET",
"fusion",
"previously",
"treated",
"with",
"SOC",
"appropriate",
"for",
"the",
"tumor",
"type",
"and",
"not",
"eligible",... | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01737502 | 1:24:treatment | Prior radiation therapy | 2 | [
"Prior",
"radiation",
"therapy"
] | [
1,
1,
1
] |
NCT01817751 | 24:39:chronic_disease,57:76:chronic_disease,86:105:chronic_disease,116:140:chronic_disease,, | Clinically significant cardiac disease, including major cardiac dysfunction, such as uncontrolled angina, clinical congestive heart failure with New York Heart Association (NYHA) class III or higher | 2 | [
"Clinically",
"significant",
"cardiac",
"disease",
",",
"including",
"major",
"cardiac",
"dysfunction",
",",
"such",
"as",
"uncontrolled",
"angina",
",",
"clinical",
"congestive",
"heart",
"failure",
"with",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",... | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03143985 | 20:32:treatment | Patients requiring hemodialysis | 2 | [
"Patients",
"requiring",
"hemodialysis"
] | [
0,
0,
1
] |
NCT03152058 | ,12:15:chronic_disease,17:28:chronic_disease,32:43:chronic_disease | Women with HIV, Hepatitis B or Hepatitis C positive status | 2 | [
"Women",
"with",
"HIV",
",",
"Hepatitis",
"B",
"or",
"Hepatitis",
"C",
"positive",
"status"
] | [
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT03036280 | 38:55:chronic_disease, | has been hospitalized or treated for suicidal behavior in the past 5 years | 2 | [
"has",
"been",
"hospitalized",
"or",
"treated",
"for",
"suicidal",
"behavior",
"in",
"the",
"past",
"5",
"years"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02285101 | 13:20:chronic_disease,22:27:chronic_disease,31:54:chronic_disease | Significant hepatic, renal or bone marrow dysfunction indicated by | 2 | [
"Significant",
"hepatic",
",",
"renal",
"or",
"bone",
"marrow",
"dysfunction",
"indicated",
"by"
] | [
0,
2,
0,
2,
0,
2,
2,
2,
0,
0
] |
NCT02498613 | 11:20:treatment,17:20:treatment,25:27:treatment,97:102:cancer,98:102:cancer,104:108:cancer | screening brain MRI (or CT if MRI contraindicated) will be required for patients with recurrent NSCLC, TNBC, or SCLC; brain MRI (or CT if MRI contraindicated) is required for PDAC if clinically suspected by patient's symptoms or neurological exam | 2 | [
"screening",
"brain",
"MRI",
"(",
"or",
"CT",
"if",
"MRI",
"contraindicated",
")",
"will",
"be",
"required",
"for",
"patients",
"with",
"recurrent",
"NSCLC",
",",
"TNBC",
",",
"or",
"SCLC",
";",
"brain",
"MRI",
"(",
"or",
"CT",
"if",
"MRI",
"contraindica... | [
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.